Pregnancy and other factors associated with higher CD4+ T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002

MedGenMed Medscape General Medicine

Volumn 7, Issue 1, 2005, Pages

  Wotring, Linda L ^a   Montgomery, JoLynn P ^a   Mokotoff, Eve D ^a   Unungu, Joseph N ^a   Markowitz, Norman ^b   Crane, Lawrence R ^c  

^a MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GENDER; HEALTH CARE FACILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NONHUMAN; PREGNANCY; PRENATAL CARE; RACE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UNITED STATES; VIRUS TRANSMISSION;

EID: 25144513087     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. US Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005. January 2001. Available at: www.cdc.gov/nchstp/od/news/prevention.pdf Accessed February 10, 2005.
2. US Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332.
3. Yeni PG, Hammer SM, Carpenter CJ, et al. Antiretroviral treatment for adult HIV infection in 2002. JAMA. 2002;288:222-235.
4. Kaufmann GR, Bloch M, Finlayson R, et al. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS. 2002;16:359-367.
5. Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years. Arch Intern Med. 2003;163:2187-2195.
6. Palella FJ, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620-626.
7. Florence E, Lundgren J, Dreezen C, et al. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med. 2003;4:255-262.
8. Floridia M, Fragola V, Galluzzo CM, et al. HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial. HIV Med. 2002; 3:75-84.
9. Mokotoff ED, Malamud BH, Kent JB, et al. Progress toward elimination of perinatal HIV infections - Michigan, 1993-2000. MMWR Morb Mortal Wkly Rep. 2002;51:93-97.
10. Michigan Compiled Laws, Sec. 333.5123(1).
11. Schuman P, Jones TB, Ohmit S, et al. Voluntary HIV counseling and testing of pregnant women - an assessment of compliance with Michigan public health statutes. Medscape General Medicine. 2004;6(2). Available at: http://www.medscape.com/viewarticle/475007 Accessed February 3, 2005.
12. Farizo KM, Buehler HW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992;267:1798-1805.
13. US Centers for Disease Control and Prevention. HIV/AIDS Reporting System (HARS) User Manual: Version 2.0. Atlanta, Ga: US Centers for Disease Control and Prevention; 1995.
14. US Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:RR-17.
15. US Centers for Disease Control and Prevention. Estimated number of adult/adolescent AIDS cases, by sex, exposure category and year of diagnosis, United States. HIV/AIDS Surveillance Report. 2000;12:1-44. Available at: http://www.cdc.gov/hiv/stats/hasr1202.pdf Accessed February 10, 2005.
16. Schmidt MA, Mokotoff ED. HIV/AIDS surveillance and prevention: improving the characterization of HIV transmission. Public Health Rep. 2003;118:197-204.
17. Tuomala RE, Kalish LA, Zorilla C, et al; Women and Infants Transmission Study. Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. Obstet Gynecol. 1997;89:967-974.
18. Vimercati A, Greco P, Lopalco PL, et al. Immunological markers in HIV-infected pregnant and non-pregnant women. Eur J Obstet Gynecol Reprod Biol. 2000;90:37-41.
19. Weisser M, Rudin C, Battegay D, et al; Swiss HIV Cohort Study and the Swiss Collaborative HIV and Pregnancy Study. Does pregnancy influence the course of HIV infection? J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:404-410.
20. Alliegro M, Dorrucci M, Phillips AN, et al; Italian Seroconversion Study Group. Incidence and consequences of pregnancy in women with known duration of HIV infection. Arch Intern Med. 1997;157:2585-2590.
21. Buskin SE, Diamond C, Hopkins SG. HIV-infected pregnant women and progression of HIV disease. Arch Intern Med. 1998;158:1277-1278.
22. Saada M, Le Chenadec J, Berrebi A, et al; SEROGEST and SEROCO Study Groups. Pregnancy and progression to AIDS: results of the French prospective cohorts. AIDS. 2000;14:2355-2360.
23. Newell M-L, Rudin C, Cunn D, Peckham C. Immunological markers in HIV-infected pregnant women. The European Collaborative Study and the Swiss HIV Pregnancy Cohort. AIDS. 1997;11:1859-1865.
24. vanBenthem BHB, Vernazza P, Coutinho RA, et al; European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS. 2002;16:919-924.
25. Gray RH, Wawer MJ, Serwadda D, et al. Population-based study of fertility in women with HIV-infections in Uganda. Lancet. 1998;351:98-103.
26. Blair JM, Hanson DL, Jones JL, et al. Trends in pregnancy rates among women with human immunodeficiency virus. Obstet Gynecol. 2004;103:663-668.
27. Ross A, Van der Paal L, Lubega R, et al. HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS. 2004;18:799-804.
28. Gupta SB, Gilbert RL, Brady AR, et al; CD4 Surveillance Scheme Advisory Group. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. AIDS. 2000;14:853-861.
29. Delmas M-C, Jadand C, DeVincenzi I, et al; SEROCO Study Group. Gender differences in CD4+ cell counts persist after HIV-1 infection. AIDS. 1997;11:1071-1073.
30. Hutchinson CM, Wilson C, Reichart CA, et al. CD4 lymphocyte concentrations in patients with newly identified HIV infection attending STD clinics. JAMA. 1991;266:253-256.
31. Luby S, Jones J, Horan J. Using CD4 counts to evaluate the stages of epidemiology of HIV infections in South Carolina Public Clinic Patients. Am J Public Health. 1994;84:377-381.
32. US Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV/AIDS Prevention, Surveillance Branch. Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance - United States, 1994-2000. MMWR Morb Mortal Wkly Rep. 2002;51:595-598.
33. CDC Collaborative Group. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. AIDS. 1997;11:1509-1517.
34. Biber CL, Jaker MA, Kloser P, et al. A study of sex differences in presentation for care of HIV. AIDS Patient Care STDs. 1999;13:103-110.
35. Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185:1818-1821.
36. Maini MK, Gilson RJC, Chavda N, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med. 1996;72:27-31.
37. Easterbrook PJ, Ye LM, Goetghebeur E, et al. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS. 2000;14:561-571.
38. Swindells S, Cobos DF, Lee N, et al. Racial/ethnic differences in CD4 T cell count and viral load at presentation for medical care and in follow-up after HIV-1 infection. AIDS. 2002;16:1832-1834.
39. US Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States - 2002. HIV/AIDS Surveillance Report. 2002;14:1. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm Accessed February 3, 2005.
40. HIV/AIDS Surveillance Section, Communicable Diseases and Immunization Division, Michigan Department of Community Health. Quarterly HIV/AIDS analysis. January 1, 2002. Available at: http://www.michigan.gov/mdch) Accessed February 3, 2005.
41. Inungu JN. An analysis of the serostatus approach to fighting the HIV epidemic. Am J Public Health. 2002;92:331.
42. Walensky RP, Losina E, Steger-Craven KA, et al. Identifying undiagnosed human immunodeficiency virus. Arch Intern Med. 2002;162:887-892.
43. Stanley B, Fraser J, Cox NH. Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent. BMJ. 2003;326:1174.